StockNews.com Initiates Coverage on Edap Tms (NASDAQ:EDAP)

Analysts at StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP) in a note issued to investors on Sunday. The firm set a “hold” rating on the medical equipment provider’s stock.

EDAP has been the subject of several other research reports. Piper Sandler reduced their price target on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a report on Friday, March 28th. Jefferies Financial Group reissued a “hold” rating and issued a $2.00 price objective (down previously from $8.00) on shares of Edap Tms in a research note on Friday, April 4th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $19.00 target price on shares of Edap Tms in a research report on Friday, March 28th.

Edap Tms Stock Down 2.8 %

Shares of NASDAQ:EDAP opened at $1.38 on Friday. The business’s 50 day moving average is $2.24 and its 200 day moving average is $2.37. The stock has a market cap of $51.20 million, a P/E ratio of -2.12 and a beta of 0.12. Edap Tms has a 52-week low of $1.26 and a 52-week high of $7.73. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. The business had revenue of $22.69 million for the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. Sell-side analysts predict that Edap Tms will post -0.6 EPS for the current year.

Institutional Trading of Edap Tms

A number of institutional investors have recently modified their holdings of the company. Illumine Investment Management LLC bought a new position in shares of Edap Tms during the 4th quarter worth approximately $50,000. BNP Paribas Financial Markets grew its holdings in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 4,400 shares during the last quarter. Jane Street Group LLC grew its holdings in Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73,361 shares during the last quarter. Millennium Management LLC increased its position in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 33,558 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC lifted its holdings in shares of Edap Tms by 48.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after purchasing an additional 52,500 shares during the last quarter. 62.74% of the stock is currently owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.